Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

October 27, 2020

Primary Completion Date

December 24, 2027

Study Completion Date

December 24, 2029

Conditions
Non Muscle Invasive Bladder CancerHigh-grade Ta/ T1 Papillary Disease Bladder Cancer
Interventions
BIOLOGICAL

Cretostimogene Grenadenorepvec

Engineered Oncolytic Adenovirus

OTHER

n-dodecyl-B-D-maltoside

Transduction-enhancing agent.

Trial Locations (72)

204

Keelung Chang Gung Memorial Hospital, Keelung

10408

National Cancer Center, Goyang-si

17601

Keystone Urology Specialists, Lancaster

19104

University of Pennsylvania, Perelman School of Medicine, Philadelphia

20010

MedStar Hospital, Washington D.C.

21076

Chesapeake Urology, Severna Park

27710

Duke University, Durham

29572

Carolina Urologic Research Center, Myrtle Beach

30322

Emory University, Atlanta

32224

Mayo Clinic - Jacksonville, Jacksonville

33612

Moffit Cancer Center, Tampa

37209

Urology Associates- Nashville, Nashville

37232

Vanderbilt University Medical Center, Nashville

38138

Conrad Pearson Clinic, Germantown

40447

China Medical University Hospital, Taichung

43614

University of Toledo, Toledo

46143

Urology of Indiana, Greenwood

49241

Pusan National University Hospital, Busan

50612

Pusan National University Yangsan Hospital, Gyeongsang

55905

Mayo Rochester, Rochester

58128

Chonnam National University Hwasun Hospital, Jeongnam

63109

Mercy Medical Center, St Louis

63130

Washington University, St Louis

63141

Specialty Clinical Research of St. Louis, St Louis

66160

University of Kansas, Kansas City

67226

Wichita Urology, Wichita

70508

Southern Urology, Lafayette

72211

Arkansas Urology, Little Rock

77027

Houston Metro Urology, Houston

78229

Urology San Antonio, PA, San Antonio

80045

University of Colorado, Aurora

80124

Urology Associates, Lone Tree

80228

Colorado Clinical Research, Lakewood

85054

Mayo Clinic Cancer Center, Phoenix

85704

Arizona Institute of Urology, Tucson

92868

University of California - Irvine, Irvine

99202

Spokane Urology, Spokane

02115

Brigham and Women's Hospital, Boston

Unknown

Barwon Health, University Hospital Geelong, Geelong

Royal Melbourne Hospital, Melbourne

Wollongong Private Hospital, Wollongong

National Cancer Center Hospital East, Chiba

Nagoya University Hospital, Fujita

Hirosaki University Hospital, Hashimoto

Chugoku Rosai Hospital, Hiroshima

Shinshu University Hospital, Ishizuka

University of Tsukuba Hospital, Kandori

Nara Medical University Hospital, Kashihara

The Jikei University Kashiwa Hospital, Kashiwa

St. Marianna University Hospital, Kikuchi

National Hospital Organization Kyoto Medical Center, Kyoto

Kagawa Rosai Hospital, Marugame

Keio University Hospital, Matsumoto

Okayama University Hospital, Okayama

Osaka City University Hospital, Osaka

Osaka Medical and Pharmaceutical University Hospital, Osaka

Kitsato University Hospital, Sagamihara

Saitama City Hospital, Saitama

Sapporo Medical University Hospital, Sapporo

Shizuoka General Hospital, Shizuoka

Keio University Hospital, Tokyo

Toyoma University Hospital, Toyoma

Ehime University Hospital, Tōon

Wakayama Medical University Hospital, Wakayama

National Hospital Organization Yokohama Medical Center, Yokohama

Korea University Anam Hospital, Seoul

Severance Hospital, Seoul

The Catholic University of Korea, Seoul

Keelung Chang Gung Memorial Hospital, Keelung

National Taiwan University Hospital, Taipei

Taipei Veterans General Hospital, Taipei

03080

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CG Oncology, Inc.

INDUSTRY